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Abstract
Background: Kyrgyzstan, where HIV is concentrated in prisons and driven by injection drug use, provides a prison-
based methadone maintenance therapy program as well as abstinence-oriented therapeutic community based on
the 12-step model called the “Clean Zone.” We aimed to qualitatively assess how prisoners navigate between these
treatment options to understand the persistence of the Clean Zone despite a lack of evidence to support its
effectiveness in treating opioid use disorders.
Methods: We conducted an analysis of policy documents and over 60 h of participant observation in February
2016, which included focus groups with a convenience sample of 20 therapeutic community staff members, 110
prisoners across three male and one female prisons, and qualitative interviews with two former Clean Zone
participants. Field notes containing verbatim quotes from participants were analyzed through iterative reading and
discussion to understand how participants generally perceive the program, barriers to entry and retention, and
implications for future treatment within prisons.
Results: Our analyses discerned three themes: pride in the mission of the Clean Zone, idealism regarding addiction
treatment outcomes against all odds, and the demonization of methadone.
Conclusion: Despite low enrollment and lack of an evidence base, the therapeutic community is buttressed by the
strong support of the prison administration and its clients as an “ordered” alternative to what is seen as chaotic life
outside of the Clean Zone. The lack of services for Clean Zone patients after release likely contributes to high rates
of relapse to drug use. The Clean Zone would benefit from integration of stabilized methadone patients combined
with a post-release program.
Keywords: Prisons, Kyrgyzstan, Substance use disorders, Therapeutic community, Opioid agonist treatment, People
who inject drugs
Background
Throughout the world, and specifically within Eastern
Europe and Central Asia (EECA), incarceration, sub-
stance use disorders (SUDs), and HIV are inextricably
linked [1]. The region’s proscriptive and punitive drug
policies [2] concentrate individuals with past or current
history of injection drug use within the criminal justice
system. Kyrgyzstan is experiencing a rapidly expanding
HIV epidemic concentrated among people who inject
drugs (PWID), primarily with heroin. Both HIV preva-
lence and within-prison drug injection remain high [3].
Without utilization of evidence-based HIV prevention
interventions, these individuals often engage in high
risk-taking behaviors that are likely to result in transmis-
sion of blood-borne infections to others in prison and
community settings. Furthermore, once prisoners are re-
leased into the community, those who continue to use
drugs are more likely to experience adverse health
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consequences and be re-incarcerated, establishing a cycle
of imprisonment and release. In the absence of policies
that favor community treatment over incarceration, the
criminal justice system should be harnessed as a means
to curbing the intersecting epidemics of mass incarcer-
ation of PWID, HIV, and substance use disorders.
There are few evidence-based treatments available in
prisons worldwide, where care often falls below commu-
nity standards [4, 5]. Unlike in most countries, Kyrgyzstan
is one of eight countries that provide all 15 internationally
recommended HIV prevention strategies in prison [6].
Specifically, it provides a range of health services for pris-
oners with SUDs including prison-based needle & syringe
programs (PNSPs), opioid agonist therapies (OAT) using
maintenance with methadone, and therapeutic communi-
ties including an abstinence-only prison facility. PNSPs
markedly reduce needle sharing and HIV transmission
[7–9]. OAT is internationally recognized as the most ef-
fective treatment for chronic opioid dependence as well as
one of the most effective primary and secondary HIV pre-
vention strategies available [10]. When continued after re-
lease, it also significantly reduces post-release mortality
[11]. Therapeutic communities are structured environ-
ments where behavioral treatment of substance use disor-
ders promotes peer support to improve drug use and
social outcomes, often involving drug-free facilities and
12-step Narcotics Anonymous programs [12]. Therapeutic
communities are most effective in patients with polysub-
stance use disorders but fare poorly relative to OAT in pa-
tients with opioid use disorders [13]. In prison contexts,
therapeutic communities show mixed results, with only
short-term reductions in substance use and re-
incarceration, especially without a sustained aftercare pro-
gram post-release [14]. Indeed, in a recent study of newly
released prisoners with opioid use disorders in Malaysia,
those who had received 24 months of therapeutic commu-
nity support during detention were significantly less likely
(10 vs 40%; p < 0.001) to have remained free from opioids
within 12 months as compared to those who received vol-
untary methadone maintenance treatment [15].
Despite the absence of data supporting the use of re-
habilitation facilities based on the 12-step model, doc-
tors, employers, and judges regularly refer patients with
SUDs to these treatment programs. Why the model has
popularity among providers and clients and how
they perceive it to work even in the presence of subopti-
mal results remain to be explored. Kyrgyzstan provides a
valuable case study as the only post-Soviet country to
have such an abstinence-only treatment facility inte-
grated into the criminal justice system. This independent
unit embedded within a prison and known as the “Clean
Zone” has provided a 12-step treatment model over the
past 10 years but has not previously been independently
assessed. Moreover, an understanding of its cultural
significance may help shed light on the persistence of
such programs despite the lack of corresponding evi-
dence attesting to its effective treatment of SUDs. Such
an assessment can help ensure a culturally appropriate
solution to the future of 12-step models in EECA
prisons, especially considering that Kyrgyzstan serves as
a regional leader on HIV/AIDS prevention and treat-
ment policies [16]. Given recent plans to expand the
abstinence-only treatment throughout the country, this
study aims to qualitatively assess how and why the Clean
Zone is being supported in order to guide the develop-
ment of appropriate programs in a region with an urgent
need to harness the criminal justice system to treat
SUDs and prevent HIV.
Methods
Focus groups with therapeutic community clients and indi-
vidual interviews with staff members were conducted in
February 2016. These were complemented by a review of
secondary data sources and policy documents on the im-
plementation of the 12-step program and the “Clean Zone”
prison in Kyrgyzstan.
Description of the Atlantis and Clean Zone programs
In Kyrgyzstan, where the prison population is 7683 [17],
30.4% of prisoners report prior drug injection [5], with 86%
of these having done so within prison [5]. Before introdu-
cing the “Clean Zone,” a 12-step rehabilitation program
based on the Atlantis Model [18] was introduced and is
now available in eight Kyrgyz prisons. These Atlantis pro-
grams differ in each facility by virtue of whether partici-
pants are housed privately from other prisoners. Entry is
voluntary, but participation requires extensive participation
in group therapy sessions and workshops with trained so-
cial workers for up to 18 months. Participants must sign a
pledge to reject all psychoactive substances including medi-
cations to treat psychiatric or substance use disorders pre-
scribed by physicians. Graduates of the Atlantis program
may opt to return to their prison units or transfer to the
Clean Zone. Eligibility to transfer to the Clean Zone is
stringent and requires a review of their participation in
Atlantis and an interview with the Director of the Clean
Zone to ensure their commitment to a “drug-free” lifestyle.
The Clean Zone concept emerged from guidance from
Pawel Moczydlowski, a Polish criminal justice expert, who
saw it as a space for the prison administration to regain
control of prisons overrun by a strong prison subculture
powered by an illicit drug trade. The aims of the Clean
Zone were to reduce recidivism, decrease the drug trade
and drug use within prison, and prevent transmission of in-
fectious diseases. Kyrgyzstan’s Clean Zone opened in 2010
and provides markedly improved living conditions and a
number of vocational programs for clients.
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Study questions
The aim of the study was to conduct a qualitative and
independent assessment of the functioning of the “Clean
Zone” and provide recommendations to prison adminis-
trators and funders. In doing this, we combined princi-
ples of inductive and deductive reasoning [19]. Through
qualitative interviews with various stakeholders, we
sought to answer the following study questions that ad-
dressed both pre-determined codes and themes that
emerged during fieldwork:
1. What are the barriers and facilitators to entry and
retention in the Clean Zone program?
2. What information is available on the effects of this
program on the treatment of SUDs among clients
within prison and after release?
3. Is the program being conducted with an efficient use
of resources?
4. How is the “Clean Zone” program viewed by both
prisoners and staff and how does this compare to
attitudes regarding OAT in treating opioid use
disorders?
5. How can the program be improved to better meet
the health needs of prisoners with SUDs?
Study sites and sampling of study participants
Three researchers (FLA, LA, JR) visited four sites, in-
cluding the Clean Zone and three Atlantis programs
over one week in February 2016 and spent over 60 h
conducting participant observation as well as focus
groups with a convenience sample of participants (110
currently incarcerated prisoners across four prison-
s—three male and one female—two released former
Clean Zone participants who currently work in local
NGOs that assist prisoners upon release) and staff mem-
bers (N = 20) of the therapeutic community. The choice
of the Atlantis sites, made by the prison administration,
was motivated by their proximity to the capital city of
Bishkek. Of the three Atlantis centers visited, one was
cordoned off from the rest of the prison, creating an iso-
lated environment similar to the Clean Zone. The Clean
Zone is an independent unit located on the territory of
Prison 31. Eligible study participants included prisoners
(participants of the Atlantis and Clean Zone programs),
staff (Atlantis and Clean zone), prison administrators,
and released Clean Zone participants (NGOs).
Data collection
Both clients and staff were involved in individual in-
depth interviews and focus groups. The Clean Zone staff
also provided administrative records that were reviewed.
Additional observation of the Atlantis and Clean Zone
environments were also conducted to better understand
the treatment delivery context. This included sitting in
during group 12-step meetings. When available and ap-
propriate, we also employed analysis of policy docu-
ments (such as the care-provision protocols used by
Atlantis staff members). Focus groups and interviews
were advertised to a group of potential participants. It
was made clear that participation would not affect their
stay in the prison, all questions would be voluntary, and
all responses would be anonymous.
A topic guide was used for each focus group and
individual interview, which was developed iteratively
through a combination of lines of questioning from
emerging findings and pre-conceived markers of pro-
gram evaluation literature [20]. The guides covered day-
to-day experiences and history within the programs, atti-
tudes toward addiction treatment, barriers to entry and
retention, social support, and anticipated challenges after
release from prison. With Atlantis clients, we led two
focus groups at two men’s programs and one focus
group at the women’s program, and with the Clean Zone
clients, we conducted one focus group. Individual in-
depth interviews were conducted with Atlantis and
Clean Zone staff which included the director of the pro-
gram and social workers from all three prisons and two
“graduates” of the Clean Zone program who were
already released from prison and working with NGOs
that provide services to prisoners.
Upon consultation with the prisons department, focus
groups were not audio-recorded to ensure participants’
comfort and openness of the discussion of sensitive topics
as well as the expression of diverse opinions within the
group. This was also relevant as one of the authors did not
speak Russian and thus interactions between the re-
searchers and the participants were mediated by interpret-
ation provided by the other two researchers. All focus
groups lasted about 90 min and interviews lasted 30–
45 min. Instead of audio-recording, extensive field notes
were taken by three of the authors during the focus groups
and participant observation. Field notes included verbatim
quotes of particular salience from participants. These inter-
views were supplemented by informal conversations we
had with our colleagues in Kyrgyzstan and in Ukraine—-
such as the staff of the non-governmental organization
AIDS Foundation East-West, the NGO “Ranat” in Bishkek,
and the Ukrainian Institute for Public Health Policy. These
meetings gave us a sense of the public profile that the Clean
Zone and Atlantis have.
Analysis
First, we assessed the effectiveness of the program based
on analysis of policy documents and interviews with
study participants (study questions 1–3). Based on scant
evidence attesting to the long-term effectiveness of
therapeutic communities in treating SUDs [21, 22] and
deficiencies in the performance of the Clean Zone, we
Azbel et al. Harm Reduction Journal  (2017) 14:43 Page 3 of 9
then sought to understand the motivation for continued
government support of abstinence-based treatment even
where methadone maintenance therapy was readily
available (study question 4).
Extensive field notes were analyzed to draw conclu-
sions from unstructured observations [23]. Immediately
after the focus groups, the three authors who conducted
the fieldwork debriefed to share observations and field
notes that were taken during debriefing sessions. Field
notes included everyday lived experiences of both pris-
oners and staff members, their understanding of addic-
tion and addiction treatment, their healthcare needs,
and their attitudes toward methadone- and abstinence-
based addiction treatment programs as well as observa-
tions of the participants’ interactions with each other
and staff, comfort level, and living conditions. As we
conducted our unstructured observations as a small
group of researchers with diverse backgrounds (a public
health epidemiologist currently trained as a medical
sociologist, a sociologist trained as a qualitative health
researcher, and a senior clinician scholar trained in in-
fectious diseases and addiction treatment), we capital-
ized on our interdisciplinary diversity in our analysis of
fieldwork data. Our analysis included iterative reading
and discussing our field notes and combing them for re-
curring themes that would most accurately describe and
represent the lived experiences of participants as they re-
lated to addiction treatment in Kyrgyz prisons.
Throughout our fieldwork and analyses, we discussed
how our professional and academic backgrounds shaped
our reflective “gaze” when encountering participants [24].
Through this process, we acknowledged the epistemological
limits of our comprehension of the participants’ lived expe-
riences and aimed to push these limits by triangulating our
collective understanding embedded in our diverse experi-
ences and training [25]. Most importantly, by challenging
our emerging findings from different disciplinary perspec-
tives and combing our data for possible negative cases, we
strove to maintain a balance between closeness, distance,
and honesty in our representation of participants’ lived ex-
periences and concerns [26].
Results
Prisoner participants were predominantly male (81%,
mean age 37) whereas staff participants were predomin-
antly female (67%).
With regard to the study questions, we found the
following:
How effective is the Clean Zone and the Atlantis pro-
gram at treating SUDs?
1. What are barriers and facilitators to entry and
retention in the program?
Nearly all individuals within the Atlantis program did not
advance to the Clean Zone for various reasons: (1) insuffi-
cient time left on their sentence; (2) individual preferences
not to participate, primarily due to an understanding of the
Clean Zone being a space with restricted movement and
stringent rules; (3) not deemed eligible by Clean Zone staff
who assess whether they would be optimal candidates or
not; (4) many do not complete the Atlantis program and
therefore are not eligible; and (5) stigma of being associated
as “loyal” to the prison administration rather than to other
prisoners.
2. What information is available on the effects of this
program on the treatment of SUDs among clients
within prison and after release?
This conclusion is verified and supported by the pres-
ence of prisoners in the colonies (especially in the Atlan-
tis program) who have completed the Clean Zone
previously and described their relapse trajectory in
which they are released from prison to the community,
but in the absence of employment, housing, and social
support, nearly all participants relapse and this relapse
occurs almost immediately after release. Furthermore,
the data collected by the Clean Zone staff also suggest
many patients (close to 30% in total over the 5 years of
program operation) drop out of the program either by
refusing therapy or breaking the rules of the program.
3. Is the program being conducted with an efficient use
of resources?
There are currently a maximum of 12 to 24 available slots
in each Atlantis program at eight prisons, yet in almost all
instances, they were not full. Thus, the 100-person capacity
of the Clean Zone program, with 19-funded clinical and
custodial staff, remains considerably underutilized, with the
maximum number of participants in the program at any
one time being 45. Staff reported marked difficulties in be-
ing able to recruit a sufficient number of participants from
the Atlantis program into the Clean Zone.
Why does support for the Clean Zone persist despite
the lack of evidence base?
4. How is the “Clean Zone” program viewed by both
prisoners and staff and how does this compare to
attitudes regarding OAT?
Three themes emerged that provide insight into the
cultural significance of the Clean Zone program.
Theme one: pride in the mission
The staff of the Clean Zone and Atlantis, as well as the
Clean Zone clients, presented with an omnipresent sense
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of pride toward the goals of the work they were set to
accomplish. The staff seemed to be sincere enthusiasts
who deeply enjoy their work with opioid-dependent pris-
oners; they were knowledgeable about and experienced
with the 12-step program and had also undergone vari-
ous training programs and seminars (as testified by the
numerous diplomas and certificates displayed on the
walks of their offices) to extend their appreciation and
understanding of how the 12-step program works.
The director of the Clean Zone seemed to exude a
matron-like concern for the well-being of the clients and
the performance of her duties. When she referred to her
clients, she used the word rebiata, i.e., boys, which, in
the Russian language, has affectionate and slightly pat-
ronizing undertones used when a senior person makes a
reference to a junior person under their wing. Further-
more, the director of the Clean Zone performed the
functions of the matron by advocating for her charges
toward various organizations like NGOs, trying to raise
funds to cover the expenses of keeping the facilities tidy,
well-stocked with food supplies, warm, and in a good
state of repair in winter. A former colonel of the Kyrgyz
police told us a story of how the director of the Clean
Zone went to great lengths to have a heating unit re-
placed in the facilities in the late fall a year ago to ensure
the clients have comfortable living conditions. It is our
impression that, to the clients, many of whom had no
close family, the director of the Clean Zone serves as a
parental figure, providing ongoing care and a sense of
support. Also, she performed the parental role of provid-
ing a strict moral code of conduct, and her ardent belief
in the values she was bringing forward (including not
only sobriety as such but also the idea of a productive
and socially beneficial lifestyle associated with sobriety)
enhanced the legitimacy of these values in the minds of
the clients.
Professional pride on the part of the staff was matched
by the prisoners’ enthusiasm toward the goals of sobriety
and social recovery. There was a particularly exuberant
contingent among the clients who stated that they ap-
preciated feeling a part of a community and having sup-
port of the other clients who were responsible for each
other. They stated that they also had a responsibility to
report on others who were using drugs or not behaving
“adequately.” The Clean Zone director later confirmed
this, saying that surprise drug testing is carried out in
the facility. The social support found in this program
was given a lot of value, since many of the participants
lacked this sort of support in the community.
Theme two: idealism against all odds
A strong idealism was reflected in the strict adherence
to order and the goals of sobriety in the face of a lack of
evidence for the continued effect of this program after
release. Given the challenges of post-release life and a
lack of support after release, changes for sustained sobri-
ety were bleak. Yet, staff and prisoners alike set their
aim at sobriety which was understood as complete ab-
stinence from any substance use, including legally pre-
scribed medications like methadone, for the rest of their
lives. Idealism was also visible through the prisoners’ ar-
dent insistence on stating their own exceptionality and
on how they felt being different, stronger, and more
mature—both in comparison to the rest of their peers
and in comparison to themselves prior to entering the
Clean Zone. Each of them wanted to feel as though they
were the exception, not the rule; if the rule was that
a substance use disorder was a chronic and relapsing
condition, each prisoner in the Clean Zone wished to as-
sert themselves as being an exception to this process
where relapse would not happen to somebody like them-
selves. To support this vision of their new, improved
selves, during the focus group discussions, they shared
stories how other, sicker, and/or older prisoners had
given them a kind of a blessing to pursue sobriety and a
decent life and how these other prisoners expressed trust
in their abilities and will to accomplish this goal. Yet this
idealism meant that Clean Zone clients segregated them-
selves from the rest of their extended primary peer
group of other prisoners with a SUD not only spatially
(by living in a separate facility) but also culturally, and
cultivated a sense of moral superiority.
Simultaneously, they appreciated that the level of social
support that was accessible to them through Atlantis pro-
grams and/or Clean Zone was unattainable upon release:
many prisoners had no families and no home to return to
and many worried about jobs and income. Only three
former clients of the Clean Zone had jobs in NGOs and
six had volunteer positions, with the others’ employment
situation being uncertain. Only 67 released Clean Zone
clients maintained contact with the Clean Zone and were
known to be abstaining from using substances. In the face
of such unlikely prospects for success, clients however
persisted in their wish to be the exception and not the
rule. While the staff and the prisoners appreciated that the
lack of services upon release may present a challenge, they
felt that the prisoners’ willpower would be the principal
tool to keep them sober. When we spoke to the two grad-
uates of the Clean Zone program, however, they recog-
nized the need for a transitional program after release,
saying “being confronted with reality on the other side,
you’re faced with social problems, you continue using”
and “if there’s no continuation of the Clean Zone, all the
effort put into them here is useless.” They estimated that
about 80% of inmates have no passports and no ability to
get a passport, so that after release, they often return to il-
legal activities since a passport is necessary to find
legal employment.
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Theme three: the demonization of methadone
The staff and the prisoners demonstrated a strong suspi-
cion toward methadone which they did not view as a
treatment, but, rather, demonized and feared it. This ex-
posed a process of “othering” and seeing “us” (i.e., clients
of the Clean Zone) versus “them” (i.e., those who are not
strong enough, including those on methadone). Also, we
detected a certain moral superiority in the prisoners’ dis-
course: for example, one prisoner in the Clean Zone
during the focus group recounted a story of how an
older prisoner who had taken him under his wing had
instilled in him a fear of methadone as something he
had taken but that is best avoided. The prisoner felt that
“all eyes were on him” as he was going to try and ac-
complish the goals of sobriety that his (older and more
senior) fellow prisoners had not been able to achieve.
Prisoners who had chosen the Clean Zone were viewed
and felt themselves as more advanced on the way to re-
covery than methadone patients. The idea that metha-
done patients could potentially share Clean Zone or
Atlantis resources (as the resources in the Clean Zone
were underutilized since it was functioning well below
its capacity) was rejected vehemently by prisoners and
by the staff. Those on methadone were not considered
sober or “clean” by participants or staff and methadone
patients were not seen as being on the path to recovery.
This perspective points to the understanding of metha-
done as not being a viable treatment and therefore irre-
concilable with the goals of the Clean Zone.
Discussion
This study is the first to evaluate and describe an
abstinence-only program in a criminal justice setting of
EECA. It is particularly important to understand the per-
sistence of the “Clean Zone” program in Kyrgyzstan,
where opioid-dependent prisoners choose between inter-
nationally recommended HIV prevention services—NSP
and methadone maintenance treatment (MMT)—and an
abstinence-only 12-step treatment. Our fieldwork ex-
plored patient and provider perspectives about the pro-
gram as well as analyzed the performance of the Clean
Zone. In light of a worldwide literature attesting to the
limited efficacy of 12-step programs in treating opioid
dependence as well as the poor resource allocation of
the Clean Zone, the program is buttressed by both the
prison administration and its participants. We argue that
negative attitudes among OAT participants undermine
the path to recovery for opioid addiction, relegating ad-
diction treatment with OAT to an inferior position in
comparison to abstinence-only programs, despite the
international literature supporting it to be the most ef-
fective treatment for opioid addiction. Here, we explore
the cultural value attributed to the Clean Zone program,
particularly in relation to social standing within the
prisoner subculture, which must be understood in order
to proceed with the effective implementation of drug
treatment in the Kyrgyz as well as other EECA criminal
justice systems.
While no systematic research assessment of the Clean
Zone’s effectiveness has been conducted to date, our in-
terviews with staff and participants, as well as the data
collected and shared with us by the Clean Zone staff,
suggest that relapse to alcohol and drug use is high
among the Clean Zone’s former patients. This is consist-
ent with the overwhelming majority of evidence, which
shows that 12-step programs have only a 5 to 15% suc-
cess rate at abstinence from long-term opioid dependent
persons, which is hardly better than no treatment at all
[27, 28]. There is a glaring lack of services for Clean
Zone patients after release from prison, which likely at-
tributes to the patients’ high rates of relapse to drug use.
The review of the literature suggests that any within-
prison addiction treatment, especially those that use
therapeutic community strategies like those in the Clean
Zone and Atlantis, may only be effective if the continuity
of services is available long-term and continue after re-
lease. Studies demonstrate that between 25 and 55% of
clients of therapeutic communities relapse to drug use
after 12 to 18 months [29]. The best evidence for addic-
tion treatment in prisoners who do not receive OAT is
with therapeutic communities where intensive treatment
started inside the prison, is continued for 6 to 18 months
after release and includes an array of vocational and em-
ployment services in the community [29–31]. Thus, the
key concern is that the current Clean Zone has no after-
care activities. Women prisoners have no access to the
Clean Zone, so they cannot continue the 12-step pro-
gram beyond Atlantis. Even the Atlantis program in the
female prison remains underutilized. Nonetheless, creat-
ing a special Clean Zone for women remains the prison
administration’s priority—a questionable use of scarce
resources. Women participants of the Atlantis program
pointed to the lack of aftercare services as their main
concern, including both assistance with finding stable
transitional housing, employment, obtaining a passport,
other legal documents, help with re-integration into the
community, and social and psychological support. Dor-
mitory facilities for released prisoners, which used to be
available through local NGOs, are now almost inaccess-
ible or closed due to the lack of funding.
Our analysis revealed that the Clean Zone program’s
resources and capacity are highly underutilized. The At-
lantis program—the only feeder pathway to the Clean
Zone—acts as a bottleneck to the Clean Zone which is
operating significantly under capacity. The perception
among other prisoners that those who enter the Clean
Zone are “traitors”—fleeing prisoner life to hide in the
secluded Clean Zone for their offenses against the
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prisoner subculture—emerged as an especially strong
driving force against entering the program. This lends
weight to the argument that it is not the lack of effect-
iveness but, rather, the social standing among peers that
plays a greater role in disincentivizing the Clean Zone.
Further qualitative research should explore prisoner sub-
culture in shaping decisions for the treatment of opioid
dependence.
Despite the lack of evidence for recovery and the
strong opposition to the program among the prisoner
population in general, a strongly minded minority de-
cides to take part in the Clean Zone. This idealism, as
noted in research elsewhere within EECA [32], is com-
mon when housed in a protected environment. A study
from Ukraine demonstrated that recovery from addic-
tion and treatment with OAT were predominantly
viewed as mutually exclusive processes [33]. Important
from this study is that current prisoners exhibited higher
optimism about changing their drug use, were less likely
to endorse methadone, and reported higher intention to
recover from their addiction compared to a similar
group of recently released prisoners who were now in
the community. A recent study by the the National
Academies of Sciences, Engineering and Medicine [34]
found that being prescribed methadone maintenance is
not inconsistent with the ideals of recovery, which allows
for new opportunities for treating opioid use disorders.
Our recommendations for the Clean Zone program
are to:
Recommendations
– Establish a transitional program for soon-to-be-re-
leased Clean Zone clients that continues 6 to
18 months after release, including shelter, social re-
habilitation, linkages to employment, and prepar-
ation of legal documents. This can be accomplished
at no additional costs by cost-shifting from the 100
bed prison unit to aftercare activities post-release.
– Create similar rehabilitation opportunities for
methadone patients who are not using illegal
substances. A Clean Zone for stable methadone
patients would be equally beneficial to them,
provide opportunities for transitional care, and
address the negative and undermining attitudes of
Clean Zone participants toward OAT. Such a
strategy of integrating methadone patients into
the underutilized Clean Zone should proceed in
order to align goals for recovery for all patients
who are not using illegal substances.
– Remove the barriers to entering the Clean Zone in
order to fill to capacity, which would minimally
include stable methadone patients that have as their
goal to remain off of illegal substances.
Limitations
The data are limited by its cross-sectional assess-
ment and non-representative nature. Using qualita-
tive data can be useful for program development,
however, especially as a quantitative assessment
would not be reasonable here given the lack of
worldwide literature to support abstinence-only pro-
grams. In this case, a qualitative study can better ad-
dress the stakes that are involved in participants
making choices for or against therapeutic community
treatment or methadone maintenance for their opi-
oid dependence.
Conclusions
The low level of interest in the Clean Zone by prisoners
themselves and high staff-to-client ratio suggest that, if
the Clean Zone were to be continued, it would benefit
from integration of stabilized methadone patients com-
bined with a post-release aftercare program. The extraor-
dinarily hostile and negative attitudes toward methadone
maintenance treatment, however, persist among patients
in the Atlantis program and the Clean Zone. This per-
ception may, in part, have evolved from methadone be-
ing originally introduced as a harm reduction strategy
alongside PNSPs, rather than as an evidence-based treat-
ment for opioid use disorders. As such, methadone was
viewed as a means to prevent HIV transmission, but not
as an effective treatment for opioid addiction. The Clean
Zone, based on within-prison therapeutic communities,
harbors negative attitudes toward OAT, stating that indi-
viduals with addiction problems cannot be in recovery
from their addiction as long as they take any form of
psychoactive substance, including medications pre-
scribed by a physician. Indeed, programs such as the
Clean Zone run contrary to the 2013 understanding of
substance use disorders that are chronic, recurring con-
ditions. These conditions, while never cured, may be in
early (3–12 months) or sustained (>12 months) remis-
sion or effectively treated using maintenance therapy
with OAT. Moreover, SUDs may be qualified as “not
treated” when someone is in a controlled setting like an
inpatient addiction treatment unit, hospitalized, or
within a criminal justice setting [35]. The hostility to-
ward methadone observed among Atlantis and Clean
Zone patients risks making the patients feel particularly
desperate if they relapse, closing off any other treat-
ment options since methadone is not considered as a vi-
able option.
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